Increasing trend of workflow automation in pathology testing coupled increasing regulatory compliance stringency related to drug development and disease diagnosis are expected to provide lucrative growth platform to digital pathology systems market in coming eight years. Additionally, increasing advancements in the molecular diagnostics and demand for ADME toxicology studies are further expected to propel market growth. However, capital intensive nature and stringent approval norms pertaining to digital pathology expected to hurdle growth in near future.
For More Information on “Digital Pathology Market Research Reports” visit – http://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market
Digital pathology systems market is studied with respect to two segments such as technology and application. Disease diagnosis application emerged as the highest revenue generating segment owing to increasing prevalence of chronic diseases such as cancer, asthma etc. Drug discovery and development segment is also expected to register notable growth over the forecast period. Telepathology market segment is gaining popularity and is expected to gain market share.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Geographically, North America is expected to have the largest market share owing to increasing usage of companion diagnostics and presence of sophisticated healthcare infrastructure followed by Europe over the forecast period. Asia Pacific is expected to grow at a lucrative growth rate due to increasing disposable income coupled with increasing patient awareness levels in coming six years. Prominent industry players of this market are 3DHistech, Leica Biosystems, Mikroscan Technologies, Ventana Medical Systems, Definiens AG, Hamamatsu Photonics K.K., Indica Labs, Visiopharm and Philips Healthcare .The industry participants are trying to gain market share via capitalizing unmet needs for digital pathology by students, small labs and researchers who can’t splurge on capital intensive systems.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
Toll Free: 1-888-202-9519
Website: Grand View Research
Blog Site: http://www.mediafound.org/